Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy

BACKGROUND: The detailed treatment regimen of COVID-19 patients with hematological malignancies has been unclear, and some fatalities have occurred, although combination therapy with antiviral agents and corticosteroids has been established for moderate to severe COVID-19 patients. CASE SERIES: Case...

Descripción completa

Detalles Bibliográficos
Autores principales: Seki, Masafumi, Hashimoto, Kosuke, Kondo, Nami, Ohya, Yoshitaka, Kotajima, Futoshi, Mitsutake, Kotaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733686/
https://www.ncbi.nlm.nih.gov/pubmed/36506836
http://dx.doi.org/10.2147/IDR.S393198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733686/
https://www.ncbi.nlm.nih.gov/pubmed/36506836
http://dx.doi.org/10.2147/IDR.S393198

Ejemplares similares